VentriPoint adds Mayo Clinic to clinical trial
Article Thumbnail ImageJune 14, 2012 -- Echocardiography technology developer VentriPoint said that the Mayo Clinic will participate in a multicenter clinical trial to evaluate the firm's VMS ultrasound diagnostic tool in patients with pulmonary arterial hypertension.

To get access to this article and all of the content on AuntMinnie.com, create a free account or sign-in now.
(Helptag:PaywallArticleLoginMessage)
Member Sign In:
  MemberID or E-mail Address:
  Password:
(?)

New AuntMinnie.com Members

Becoming a Member is FREE!

  • Real-time radiology-specific news
  • Case of the Day and Teaching Files
  • Focused topics digital communities
  • Lively, discussion groups
  • Medical imaging bookstore
  • SalaryScan
  • Job Boards
  • Online CME
  • Bookstore, market reports, more …
  • Conference Calendar
  • User-controlled eNewsletters
  • … registration is FREE and easy!
  • The company said it's currently pursuing U.S. Food and Drug Administration (FDA) 510(k) clearance for VMS. The tool is cleared for sale and clinical use in Canada and Europe, VentriPoint said.


    || About || Advertising || AuntMinnieCME.com || Bookstore || Breast MRI || Career Center || Case of the Day || Communities || Conferences || Contact Us || ECR News 2013 || Education || Equipment Classifieds || Europe || Facebook || Forums || Home || Links || Marketplace || Middle East || Mobile || Molecular Breast Imaging || New Installations || News in Brief || People in the News || Privacy Policy || RSNA News 2013 || Reference || Salary Survey Results || Trends in Radiology || Twitter || Vendor Connect || Webinars || XML/RSS ||

    Copyright © 2014 AuntMinnie.com. All Rights Reserved.